ISTH 2021 Congress
Venous Thromboembolism » Cancer Associated Thrombosis
Theme Navigation
- ISTH 2021 Congress
- Venous Thromboembolism
- Cancer Associated Thrombosis
- Venous Thromboembolism
-
Abstract Number: PO188
“Heparin Failure” in Seminoma-related Dramatic Hypercoagulable Melieu and Extended Vein Thrombosis: Is it BEP Protocol Ongoing Responsible?
-
Abstract Number: OC 30.3
CDKN2A Mutational Status is Associated with Venous Thromboembolism in Patients with Glioblastoma
-
Abstract Number: PB1121
A Population-Based Descriptive Study of Long-term Anticoagulation in the Treatment and Secondary Prophylaxis of Venous Thromboembolism in Men with Prostate Cancer in Sweden
-
Abstract Number: PO165
A Rare Case of Bi-atrial Thrombi in a Stage IV Pancreatic Cancer Patient with Atrial Fibrillation on Warfarin
-
Abstract Number: LPB0090
Active Cancer and Venous Thromboembolism: Safety and Effectiveness of Edoxaban in Patients from the Noninterventional Global ETNA-VTE Program
-
Abstract Number: PB1118
Anticoagulant Therapy and Related Bleeding Complications in Internal Medicine Wards
-
Abstract Number: PB1101
Association between Cancer and Anatomical Site of Venous Thromboembolic Disease
-
Abstract Number: PB1098
Association of KRAS Mutation with Arterial Thromboembolism in Advanced Lung and Gastrointestinal Cancer
-
Abstract Number: PB1137
Biomarkers Of Thrombosis As Predictors Of Venous Thromboembolism In Cancer Patients: Preliminary Results From Fiit Project
-
Abstract Number: PB1106
Bleeding and Venous Thromboembolism Recurrence in Patients with Gastrointestinal and Genitourinary Malignancies Treated with Anticoagulation
-
Abstract Number: PB1128
Breast Cancer, Doxorubicin and Cardiotoxicity: Can Thrombin Generation Test Be Useful?
-
Abstract Number: PO171
Cerebral Thrombosis during Treatment of Childhood Acute Lymphoblastic Leukemia
-
Abstract Number: PB1091
Characteristics and Outcomes of Patients on Concurrent Direct Oral Anticoagulants and Targeted Anticancer Therapies – TacDOAC Registry
-
Abstract Number: LPB0042
Characterization of Thrombotic Risk in Patients with Cancer
-
Abstract Number: PB1119
Circulating Extracellular Vesicles in Patients with Cancer and Venous Thromboembolism: A Systematic Review and Meta-analysis
-
Abstract Number: PB1114
Clinical Risk Factors for Venous Thromboembolism in Hematologic Malignancies
-
Abstract Number: PO177
Coagulation Abnormalities At Presentation of Childhood Acute Lymphoblastic Leukemia
-
Abstract Number: PB1132
Concurrent Atypical Thrombotic Complications of Acute Promyelocytic Leukemia (APL) in an Anticoagulated Patient: A Rare Case Report
- 1
- 2
- 3
- 4
- Next Page »